the US FDA ordered revised labels on certain birth-control pills, including Yasmin, to advise of a possibly higher risk of blood clots
San Diego, CA (PRWEB) May 16, 2012
The media spotlight is often a double-edged sword. No one knows this better than women who suffer from Yasmin severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.
On April 27th, 2012 Bloomberg reported that Bayer settled lawsuits alleging that Yasmin range of pills caused blood clots in women to $142 million. Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. They are also used to treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women. Yasmin and Yaz are manufactured by Bayer Healthcare Pharmaceuticals. According to Bayer the amount per settled lawsuit is approximately $218,000. On April 13th Bloomberg reported that Bayer settled the first 500 lawsuits to approximately $110 million. The Yasmin and Yaz lawsuits filed in the federal court system are consolidated before U.S. District Judge David Herndon in the Multidistrict Litigation (MDL 2100), U.S. District Court, Southern District of Illinois (East St. Louis), where the majority of these cases are pending.
On April 10th, 2012 the US FDA ordered revised labels on certain birth-control pills, including Yasmin, to advise of a possibly higher risk of blood clots. As of April 18th, 2012, there were about 11,900 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Yasmin and Yaz.
AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Yasmin severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Yasmin remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
According to the FDA drug study published on October 27th, 2011, Yasmin and other birth control pills, containing the fourth generation progestin drospirenone, were related to an increased risk for side effects like DVT and ischemic stroke.
AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Yasmin at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/5/prweb9501363.htm.